Robots take on stomach cancer: global study aims to perfect surgery

NCT ID NCT07517432

Recruiting now Knowledge-focused Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This international registry collects data from 200 stomach cancer patients who undergo robot-assisted minimally invasive gastrectomy (RAMIG). The goal is to understand surgical techniques, outcomes, and the learning curve for surgeons. By standardizing data collection across continents, researchers hope to improve safety and effectiveness of this advanced surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: robot-assisted minimally invasive gastrectomy (RAMIG) procedure
What this could lead to: If successful, this registry could help standardize robot-assisted stomach cancer surgery and reduce complications worldwide.
What could go wrong: This is an observational registry, not a treatment trial. It collects data only, so it won't directly test a new cure or therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRECTOMY GASTRIC CANCER (DIAGNOSIS)

Contacts and locations

Locations

The Chinese University of Hong Kong, Shatin, HK
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.